Thursday, November 06, 2008

Astra Zeneca - Crestor: cutting through the CRP

``If CRP is a legitimate marker of heart disease, people with a high CRP level who are given another statin may also have some benefit,'' said Sidney Wolfe, head of Public Citizen's Health Research Group, an advocacy organization in Washington. ``No one should look at this study and say it's worth paying three or five times more for Crestor than for another statin.''

No comments: